Alexion Pharmaceuticals, Inc.

Prime Capital Investment Advisors, LLC ALXN

Report date

3/31/2021

Quarter

2021 Q1

Filed

5/7/2021

Shares

452

Value ($000)

69

Weight

0.0%

2019 Q4 - 2021 Q1 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q1	5/7/2021	69	0.0%	452	3/31/2021
2020 Q4	2/3/2021	125	0.0%	800	12/31/2020
2020 Q3	11/6/2020	109	0.0%	950	9/30/2020
2020 Q2	7/17/2020	107	0.0%	950	6/30/2020
2020 Q1	5/4/2020	86	0.0%	959	3/31/2020
2019 Q4	2/4/2020	76	0.0%	707	12/31/2019